The purpose of this feasibility study was to investigate the kinetics of CD64 expression before and during culture proven sepsis compared to clinical sepsis and suspected infection in VLBW infants between postnatal day 4 and day 28 and to test the set-up for a larger prospective trial. This evidence concerns the gene FCGR1A and infection.